Rare
lephants
Screener
Toggle theme
ATOSSA THERAPEUTICS, INC.
ATOS
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Profit History
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Profit History
Chart
Table
Revenue
Operating Income
Net Income
Fiscal Year
Revenue
Operating Income
Net Income
FY2025
—
$-37.1M
$-34.8M
Download CSV
